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Abstract
Transition row metal ions are both essential and toxic to microorganisms. Zinc in excess has significant toxicity to bacteria,
and host release of Zn(II) at mucosal surfaces is an important innate defence mechanism. However, the molecular
mechanisms by which Zn(II) affords protection have not been defined. We show that in Streptococcus pneumoniae
extracellular Zn(II) inhibits the acquisition of the essential metal Mn(II) by competing for binding to the solute binding
protein PsaA. We show that, although Mn(II) is the high-affinity substrate for PsaA, Zn(II) can still bind, albeit with a
difference in affinity of nearly two orders of magnitude. Despite the difference in metal ion affinities, high-resolution
structures of PsaA in complex with Mn(II) or Zn(II) showed almost no difference. However, Zn(II)-PsaA is significantly more
thermally stable than Mn(II)-PsaA, suggesting that Zn(II) binding may be irreversible. In vitro growth analyses show that
extracellular Zn(II) is able to inhibit Mn(II) intracellular accumulation with little effect on intracellular Zn(II). The phenotype of
S. pneumoniae grown at high Zn(II):Mn(II) ratios, i.e. induced Mn(II) starvation, closely mimicked a DpsaA mutant, which is
unable to accumulate Mn(II). S. pneumoniae infection in vivo elicits massive elevation of the Zn(II):Mn(II) ratio and, in vitro,
these Zn(II):Mn(II) ratios inhibited growth due to Mn(II) starvation, resulting in heightened sensitivity to oxidative stress and
polymorphonuclear leucocyte killing. These results demonstrate that microbial susceptibility to Zn(II) toxicity is mediated by
extracellular cation competition and that this can be harnessed by the innate immune response.
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Introduction
S. pneumoniae is the world’s foremost bacterial pathogen and a
leading cause of death in young children in developing countries
[1,2,3]. One of the major factors associated with the incidence and
severity of S. pneumoniae infections in these children is dietary zinc
deficiency (a significant ongoing problem in developing countries
[4,5]). Zinc, which occurs as the divalent cation Zn(II), is the
second most abundant transition metal in humans and has crucial
roles in many facets of the immune system [6,7]. The physiological
concentration ranges of Zn(II) range from a few mM to over
100 mM and it has been suggested that Zn(II) interacts with up to
10% of all human proteins [8,9,10]. Zn(II) concentrations are
elevated in response to inflammation and bacterial infection as a
consequence of Zn(II) release from damaged or apoptotic cells,
and from sequestering proteins such as metallothionein. Despite
the requirement of Zn(II) for optimal immune function, diseases in
developing countries associated with Zn(II)-poor status are
predominantly acute respiratory infections, otitis media and
diarrhea [7]. In recent years clinical trials of Zn supplementation
have been undertaken in developing countries and meta-analyses
of multiple trials [11,12] have shown a clear association between
Zn(II) supplementation and a reduction in the incidence and
severity of pneumonia and diarrhea. However, to date no clear
mechanism for the protective effect of Zn(II) has been identified.
Zn(II) is also an essential micronutrient for bacteria, although it
has significant toxicity at high concentrations [13,14,15,16,17].
However, the molecular basis of zinc toxicity remains poorly
defined. Studies from our laboratory have previously demonstrat-
ed that the pneumococcal surface antigen A (PsaA) from S.
pneumoniae has a clear interaction with Zn(II) [18] despite not being
involved in its uptake, which occurs via a distinct Zn(II) ATP-
binding cassette (ABC) permease [19,20]. PsaA is the solute-
binding protein (SBP) of a manganese-specific ABC permease
encoded by the psaBCA locus. Mn(II) is an essential trace element
for both prokaryotes and eukaryotes where it has roles in many
cellular processes [21]. In S. pneumoniae Mn(II) regulates a diverse
array of genes and has been shown to have roles in competence
and in managing oxidative stress [22,23]. Notably, the importance
of Mn(II) for oxidative stress management, beyond its role in
manganese superoxide dismutase, is an area of growing research.
Recently, Mn(II) was shown to be able to substitute for ferrous iron
in a nonredox metabolic enzyme to protect carbon metabolism
under conditions of oxidative stress [24]. Intriguingly, both Mn(II)
and Zn(II) are acquired by SBPs belonging to the Cluster A-1
family [25] of prokaryotic transporters [19]. The tertiary structure
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are present at the metal binding sites [26]. Mn(II) acquisition,
mediated by PsaA, is important for S. pneumoniae growth,
proliferation and virulence [27]. In S. pneumoniae, loss of psaA
results in a massive reduction of virulence in systemic, respiratory
tract and otitis media murine models of infection [27,28,29]. The
importance of Mn(II) for the virulence of bacteria has also been
observed in a number of other pathogens including Bacillus
anthracis, S. pyogenes, and Staphylococcus aureus [30,31,32]. Therefore,
as the S. pneumoniae Mn(II) ABC permease PsaBCA is essential for
growth in vivo, we hypothesized that Zn(II) could compete for
Mn(II) binding, and thereby mediate toxicity by impairing Mn(II)
acquisition.
In this paper, we present the biophysical characterization of
PsaA and show how Zn(II) competition for Mn(II) transport in vitro
impairs growth and renders S. pneumoniae hypersensitive to
oxidative and polymorphonuclear leukocyte killing. We then
illustrate the significance of these findings by showing how in vivo
host Zn(II) concentrations change in response to S. pneumoniae
infection. Taken together, this study presents a new paradigm for
the molecular basis of bacterial susceptibility to Zn(II) toxicity, due
to its extracellular competition for an essential metal ion
micronutrient transporter, and its exploitation in vivo by the host
immune response.
Results
PsaA is a high affinity Mn solute binding protein
We first determined the binding constants (KA) of Mn(II) and
Zn(II) with PsaA using isothermal titration calorimetry (ITC).
Representative binding isotherms of apo-PsaA are shown in Fig. 1A
and B (for further details see Text S1). The derived affinity
constants (
1/KA=K D) calculated for 1:1 complexes of PsaA with
Mn(II) or Zn(II) were 3.361.0 nM and 23161.9 nM, respectively.
The ITC data indicated that Zn(II) had an affinity nearly two
orders of magnitude lower than Mn(II), consistent with the role of
PsaBCA in Mn(II) acquisition under physiological conditions.
Nevertheless, the data suggested Zn(II) could compete for PsaA
binding at high concentrations.
Mn(II) and Zn(II) bind to PsaA with no apparent structural
difference to the protein
The crystal structure of PsaA had previously been determined
with Zn(II) tetrahedrally coordinated by the four metal-binding
residues (His67, His139, Glu205 and Asp280) [18] but no
structure for the Mn(II)-loaded protein has been reported. We
crystallized Mn(II)-loaded PsaA and determined its structure at
2.7 A ˚ resolution (PDB ID: 3ZTT). Well-defined and continuous
Figure 1. Biophysical characterization of purified PsaA.
(A) Representative ITC measurements for titration of 4.5 mM PsaA with
40 mM Mn(II). (B) Titration of 20 mM PsaA with 250 mM Zn(II). For each
experiment the rates of heat release are shown above the correspond-
ing plots of integrated heat. Both of the curves were fitted to a single
site (n=1) model and the KD calculated from replicate experiments
(6 SEM). (C) The overall fold of PsaA with the metal ion shown in purple
between the two domains. (D) The metal binding site. The 2FO-Fc
electron density map (contoured at the 1.0s level) is shown in blue for
the coordinating residues and the metal ion. The Mn(II) is shown as a
purple sphere and the residues are in ball-and-stick representation
(carbon atoms in green, oxygen in red and nitrogen in blue). Also
shown in orange is the anomalous difference Fourier map contoured at
the 5.0 s level, computed using the Bijvoet differences collected at the
manganese K-edge peak wavelength. (E) Thermal stability of PsaA. The
sets of curves show the thermal transition of 10 mM PsaA incubated
with 10 mM Mn(II) or 10 mM Zn(II). The curves are representative of three
independent experiments (n=3). (F) Thermal stability of PsaA with
increasing Mn(II) concentrations as indicated.
doi:10.1371/journal.ppat.1002357.g001
Author Summary
Dietary zinc deficiency is a global health problem affecting
almost two billion people. Infectious diseases associated
with zinc deficiency include respiratory infections caused
by bacteria, and notably, Streptococcus pneumoniae, which
is responsible for more than 1 million deaths annually. The
association between zinc and immunity is well known, but
the mechanism by which zinc provides protection against
infectious diseases has remained a mystery. Previously, we
found that manganese was essential for S. pneumoniae
growth and its ability to cause disease. Intriguingly, we
also observed that zinc could bind to the manganese
transport protein. Therefore, we sought to determine if
zinc could inhibit manganese transport, and to observe
what the effects would be on S. pneumoniae. We found
that zinc prevented manganese uptake. This slowed
bacterial growth and rendered it hypersensitive to
immune cell killing. We also observed that, during S.
pneumoniae infection in mice, zinc released by the host
increased to concentrations that could compete for
manganese uptake. Our study provides direct evidence
for how zinc is toxic to bacteria by preventing manganese
uptake. Furthermore, we show how this could be
harnessed by the immune system, thereby providing a
scientific basis for the protective effect of zinc against
infectious diseases.
Mechanism for Bacterial Susceptibility to Zinc
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tetrahedrally coordinated the metal ion (Fig. 1C and D), which
was identified as Mn(II) (see Text S2 for further details). The
tetrahedral coordination of Mn(II) is analogous to Zn(II)
coordination in PsaA (Fig. S1) and the structures of other Cluster
A-1 SBPs (Treponema pallidum TroA [33], Synechocystis 6803 MntC
[34], Synechocystis 6803 ZnuA [35] and E. coli ZnuA [26]). Overall,
our structural analysis indicates that PsaA is capable of binding
Mn(II) and Zn(II) with only very minor accompanying structural
changes in the final loaded state (Fig. S1C and D).
Metal ion discrimination within the Cluster A-1 SBPs is
proposed to occur through subtle differences in the binding sites,
Zn(II)-binding being favoured by the presence of three N ligands
(from His residues), and Mn(II)-binding being favoured by two N
(His) and two O (Asp or Glu) ligands [26]. We determined, by
ITC, that Zn(II) binding had a high enthalpy (DH= 218.26
0.4 kcal.mol
21) relative to Mn(II) (DH= 27.561.1 kcal.mol
21),
as would be predicted by the Irving-Williams series for the stability
of metal ion complexes [36]. However, the preference of PsaA for
Mn(II) is the result of the highly unfavourable entropic
contribution of Zn(II) binding (2TDS=9.560.4 kcal.mol
21)
relative to Mn(II) (2TDS= 24.060.9 kcal.mol
21). Thus, the
binding free energies (DG) of the PsaA-Mn(II) and PsaA-Zn(II)
complexes (211.560.2 kcal.mol
21 and 28.960.2 kcal.mol
21,
respectively) are consistent with both the preference for Mn(II)
under physiological conditions and the observed difference in
affinity of the protein (1 order of magnitude =1.41 kcal.mol
21).
Mn(II) preference for PsaA is, therefore, due to differences in the
entropic contributions.
Metal ion effects on PsaA thermal stability
We employed a thermal stability assay (TSA) to measure the
influence of Mn(II)- and Zn(II)-specific binding on the melting
temperatures (Tm) of PsaA. This assay observes the overall stability
of the folded state of the protein as a function of the Tm. Metal-ion
ligands that bind and stabilise the protein’s quaternary structure
induce a more thermo-stable structure, i.e. a higher Tm. ‘As
prepared’ PsaA (Fig. 1E) was found to have a major transition at
62.1uC, corresponding to the apo-protein, and a minor peak at
72.9uC, correspondingto the co-purifying Zn(II) form (presentin‘as
prepared’ PsaA) (Table S1). This interpretation was confirmed by
analysis of cation-free PsaA binding site point mutants that were
purified as apo-proteins (Fig. S2, Table S1). Co-incubation of PsaA
with saturating Zn(II) increased the overall Tm to 72.9uC (Fig. 1E,
Table S2). In contrast, saturating Mn(II) only increased the Tm of
the apo-PsaA to 65.1uC and did not affect the Zn(II)-PsaA complex.
Titration of Mn(II) with PsaA showed that apo-PsaA demonstrated a
stepwise increase in Tm (Fig. 1F, Table S2) from 63.2uCt o7 0 . 2 uC,
while the PsaA-Zn(II) subpopulation (72.9uC peak) was not affected
by the Mn(II) additions. In conclusion, the TSA unexpectedly
showed that Zn(II) induced greater thermal stability than Mn(II),
despite Mn(II) having a higher affinity for PsaA.
Extracellular Zn(II) competitively affects Mn(II) uptake in
Pneumococcus
We then sought to determine the phenotypic effect of Zn(II) on
PsaA-mediated Mn(II) uptake. This was assessed by in vitro metal
ion competition assays with wild-type S. pneumoniae and the DpsaA
mutant grown in the presence of differing ratios of Zn(II) in a semi-
synthetic medium. Increasing the Zn(II):Mn(II) ratio slowed
bacterial growth and at very high ratios, i.e. at 1000:1 [1000 mM
Zn(II):1 mM Mn(II)], S. pneumoniae growth was completely
inhibited (Fig. 2A). Growth was restored, albeit heavily delayed,
at Zn(II):Mn(II) ratios of 100:1 and 250:1, while at ratios of 50:1
and 10:1 Zn(II):Mn(II), S. pneumoniae growth was essentially the
same as in the basal medium (Fig. 2A). Growth at inhibitory Zn(II)
concentrations could be reversed by Mn(II) supplementation to a
1:1 ratio relative to the Zn(II) concentration (Fig. 2B), consistent
with a competitive effect of Zn(II) for PsaA. The inhibitory effect of
Zn(II) was also observed on exponential phase growing cells
Figure 2. In vitro metal competition. In vitro growth measurements
of S. pneumoniae wild-type (D39) and DpsaA. (A) Bacteria were grown in
C+Y medium consisting of the following Zn(II):Mn(II) ratios (in mM):
1000:1, 250:1, 100:1, 50:1 10:1, 1:1, and C+Y with 1 mM MnSO4,
respectively. Data are mean (6 SEM) A600 measurements from seven
independent biological experiments (n=7). (B) Bacteria were grown in
C+Y medium consisting of the following Zn(II):Mn(II) ratios (in mM):
100:1, 250:1, 100:100, 250:250, and C+Y+1 mM MnSO4 supplementation,
respectively. Data are means (6SEM) A600 measurements from seven
independent biological experiments (n=7). (C) Bacteria were grown in
C+Y medium supplemented with 1 mM MnSO4 until an A600 of 0.3 was
reached. Cells were washed in C+Y medium and then inoculated to an
A600 of 0.2 in C+Y medium consisting of the following Zn(II):Mn(II) ratios
(in mM): 100:1, 300:1, and 1000:1. Data are means (6SEM) A600
measurements from seven independent biological experiments (n=7).
(D) In vitro growth measurements of the DpsaA mutant. Bacteria were
grown in C+Y medium consisting of the following Zn(II):Mn(II) ratios
(in mM): 100:1, 10:1, and C+Y+1 mM Mn supplementation, respectively.
The wild-type S. pneumoniae D39 grown in C+Y+1 mM Mn supplemen-
tation is shown for reference. Data are means (6SEM) A600 measure-
ments from seven independent biological experiments (n=7). (E) S.
pneumoniae intracellular Zn(II) accumulation determined by ICPMS.
Data are mean (6 SEM) ng Zn(II)/g cell measurements from duplicate
measurements of 2 independent biological experiments. (F) Intracellular
Mn(II) accumulation determined by ICPMS. Data are mean (6 SEM) ng
Mn(II)/g cell measurements from duplicate measurements 2 indepen-
dent biological experiments. The statistical significance of the
differences in concentrations was determined by a two-tailed unpaired
t-test. P-values of ,0.05, ,0.005 and ,0.0005 are denoted by *, ** or
***, respectively.
doi:10.1371/journal.ppat.1002357.g002
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inhibited growth of S. pneumoniae within 120 minutes (2–3
generations). Intriguingly, high ratios of Zn(II):Mn(II) slowed the
growth rate of S. pneumoniae similar to that of the isogenic DpsaA
mutant.
Previously, our group has reported that the phenotypic effects of
a DpsaA mutant include compromised Mn(II) uptake and a slower
growth rate, relative to wild-type S. pneumoniae [28]. As the DpsaA
strain lacks PsaA, and consequently has no functional high affinity
Mn(II) importer, we predicted that the mutant would be
insensitive to Zn(II) competition. Consistent with this hypothesis,
we observed that competitive ratios of Zn(II):Mn(II), e.g. 250:1
(Fig. 2D), had no effect on the already slower growth rate of the
DpsaA mutant.
Extracellular Zn(II) exerted a clear effect on the growth rate of
S. pneumoniae. As this could occur through a number of possible
routes in a complex biological system, we sought to determine if
extracellular Zn(II) was influencing intracellular metal concentra-
tions by conducting inductively coupled plasma mass spectroscopy
(ICPMS) on S. pneumoniae grown in different Zn(II):Mn(II) ratios.
We observed that at the competitive ratio of 100:1, i.e. growth
perturbing, the concentration of Zn(II) was essentially the same as
that at the non-competitive 10:1 Zn(II):Mn(II) ratio (Fig. 2E, Table
S3). This indicated that despite the high concentration of
extracellular Zn(II), intracellular Zn(II) homeostasis was not being
disregulated. The intracellular concentrations of Zn(II) increased
nearly two-fold in the wild-type when grown in the presence of
high extracellular Zn(II) (10:1 and 100:1 Zn(II):Mn(II) ratios).
Although this had no apparent physiological effect, as demon-
strated by the 10:1 Zn(II):Mn(II) ratio, the higher intracellular
concentrations may render S. pneumoniae more susceptible to Zn(II)
toxicity if Zn(II) efflux pathways were blocked or impaired.
Collectively, these data support a model whereby high concen-
trations of extracellular Zn(II) were competitively inhibiting Mn(II)
uptake and, as the intracellular Zn(II) concentration observed for
the 100:1 and 10:1 Zn(II):Mn(II) ratios were essentially the same, it
follows that the intracellular Zn(II) and hence Zn(II) toxicity was
not due to toxic intracellular accumulation.
Zn(II) is not transported via the Psa ABC permease
The lack of significant variation in the intracellular Zn(II)
concentrations between the 100:1 and 10:1 Zn(II):Mn(II)-grown
cells suggested that Zn(II) was not transported by the Mn(II)
permease, despite the affinity of PsaA for Zn(II). This inference is
supported by comparisons with the DpsaA mutant, which lacks a
Mn(II) transporter and had similar intracellular accumulations of
Zn(II) to that of wild-type S. pneumoniae (Fig. 2E, Table S3). Taken
together these data suggest a model where PsaA-Zn(II) binding
results in an irreversible ‘‘dead end’’ complex, the physiological
basis of which could be to prevent Zn(II) leakage into the bacterial
cell through the Mn(II) transporter in the presence of high
extracellular Zn(II) concentrations. In contrast, the Mn(II)-PsaA
complex likely represents a reversible complex that, upon
interaction with the ABC permease, delivers the metal ion into
the transporter and allows apo-PsaA to be released. This model is
consistent with our biochemical observations, which found that
Zn(II) conferred very high thermal stabilisation on PsaA in the
TSA, and that Zn(II) removal required unfolding of the protein, as
it was resistant to dialysis, chelation and Mn(II) competition.
Zn(II) competition reduces intracellular Mn(II) resulting in
up-regulation of PsaBCA expression
ICPMS analysis of S. pneumoniae grown in the 100:1 Zn(II):Mn(II)
ratio showed a five-fold decrease in intracellular accumulation of
Mn(II) (P=0.002) compared to the 10:1 and 1:1 ratios (Fig. 2F
Table S3). Thus, extracellular Zn(II) was inhibiting Mn(II) uptake
by S. pneumoniae, thereby inducing a phenotype similar to a DpsaA
mutant. However, unlike the mutant strain, the 100:1Zn(II):Mn(II)-
grown S. pneumoniae had an intact high affinity Mn(II) transporter.
The residual Mn(II) uptake observed in the DpsaA mutant most
likely occurs via non-specific transport.
We then sought to determine what effect competitive ratios of
Zn(II) had on PsaBCA expression. The expression of PsaBCA is
regulated by PsaR, a DtxR family regulator, which represses
psaBCA transcription in response to Mn(II) while de-repression
occurs at low Mn(II) or high Zn(II) concentrations [37]. Under our
experimental conditions, 100:1 Zn(II):Mn(II)-grown S. pneumoniae
demonstrated slower growth and decreased intracellular Mn(II)
compared to 10:1 Zn(II):Mn(II)-grown S. pneumoniae, which had
unaffected growth. An analysis of psaA transcription and psaA
expression found that, in 100:1 Zn(II):Mn(II)-grown cells, both
were highly up-regulated relative to the 10:1 grown cells (Fig. S3A
and S3B). As the intracellular Zn(II) concentrations in both the
100:1 and 10:1 Zn(II):Mn(II)-grown S. pneumoniae were essentially
the same, the observed PsaR-dependent up-regulation of expres-
sion of the psaBCA operon would be most likely due to the Mn(II)
starvation phenotype and similar to that previously observed in the
DpsaA strain [37].
Zn(II) competition heightens sensitivity of S. pneumoniae
to oxidative killing
Mn(II) restriction in S. pneumoniae has two well established
consequences, namely a reduction in oxidative stress response
capability and a concomitant loss of in vivo virulence [23,28,29].
Therefore, to assess whether the Zn(II)-dependent inhibition of
Mn(II) uptake was inducing a DpsaA-like phenotype, we investi-
gated the capacity of 100:1 Zn(II):Mn(II)-grown S. pneumoniae to
tolerate oxidative stress mediated chemically, via paraquat or by
human polymorphonuclear leucocytes (PMNs).
Paraquat is a redox compound that generates superoxide in the
cytoplasm, and survival after exposure requires effective oxidative
stress management [23]. After 30 min. of paraquat exposure both
the 100:1 Zn(II):Mn(II)-grown S. pneumoniae and the DpsaA strain
had significantly lower survival rates (31% [P=0.046] and 18%
[P=0.040], respectively) when compared to the Mn(II) replete
wild-type S. pneumoniae (100%) (Fig. 3A). Following the hypothesis
that reduced Mn(II) accumulation results in hypersensitivity to
oxidative stress, we next examined whether this heightened
susceptibility to killing extended to human PMNs (Fig. 3B). Both
the 100:1 Zn(II):Mn(II)-grown S. pneumoniae and the DpsaA strain
had significantly lower survival rates after incubation with PMN
(13.4% [P=0.0292] and 5.0% [P=0.0285], respectively) when
compared to the Mn(II) replete wild-type S. pneumoniae (22.3%).
The increased susceptibility of the DpsaA mutant and the 100:1
Zn(II):Mn(II) grown wild-type S. pneumoniae demonstrates that
Mn(II) has a direct role in resisting PMN killing. Taken together
these data show that Zn(II) competitively inhibits intracellular
Mn(II) acquisition in S. pneumoniae leading to significantly increased
susceptibility to oxidative stress, similar to the DpsaA strain.
Infection by S. pneumoniae in vivo elicits an increase in
the Zn(II):Mn(II) ratio
The physiological consequences of Mn(II) deprivation, as a
result of Zn(II) competition in vitro, suggested that S. pneumoniae
survival in vivo could be compromised, similar to the DpsaA strain.
Therefore, we investigated the levels of Mn(II) and Zn(II), and
other cations, in tissue samples collected from naı ¨ve and S.
Mechanism for Bacterial Susceptibility to Zinc
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Mn(II) in niches that would be subject to colonization by S.
pneumoniae did not exceed ,60:1 (Table 1). Thus, the observed
ratios of Mn(II) to Zn(II) within these physiological niches should
be permissive for Mn(II) acquisition by PsaBCA. For mice infected
with S. pneumoniae, the samples harvested 48 hours post-infection
showed significantly shifted metal ratios, with Zn(II) concentra-
tions increasing in all tissues (Table 1, Fig. 3C). This effect was
largely specific for Zn(II), although minor increases were observed
with Fe(II) in the nasopharynx and the brain and Cu(II) in blood
serum (Table S4). The increase of Zn(II) was most dramatic in
blood serum and the nasopharynx, where the Zn(II):Mn(II) ratio
increased to approximately 900:1 (P=0.0292) and 330:1
(P=0.0163), respectively. The lack of variation among the
majority of other metal ions examined (Table S4) indicated that
elevation of Zn(II) has a major role in host response to S. pneumoniae
infection.
These findings were consistent with the earlier study of Strand
and co-workers [38], which found that Zn(II)-deficient mice had
heavier S. pneumoniae nasopharyngeal colonization, compared to
the Zn(II) replete mice, and only Zn(II) deficient mice had S.
pneumoniae bacteremia. The dramatic elevation of Zn(II) observed
in these two tissues, upon infection with S. pneumoniae in our study,
suggested that Zn(II) could compete with Mn(II) (which remained
largely unchanged) for PsaA interaction (Table 1, Fig. 3D) and,
therefore, demonstrate that metal ions have a role in ameliorating
bacterial propagation and dissemination in vivo.
Discussion
Although nearly 30% of all proteins contain metal ions [21], an
excess of certain transition metal ions can exert significant toxicity.
The potential roles of such metals in resisting bacterial invasion are
increasingly being recognized. Notably the importance of copper
in macrophages for bactericidal activity has recently been
demonstrated [39]. Our present study provides the first direct
evidence that extracellular Zn(II) can exert its toxicity towards S.
pneumoniae by competing with Mn(II) for binding to the PsaA solute
binding protein, thereby preventing the acquisition of Mn(II) via
the Psa permease. While our study was being completed, Jacobsen
and co-workers similarly proposed that Zn(II) toxicity results in
cytoplasmic Mn(II) deficiency, but no evidence for the mechanism
was provided [40]. We have shown that Zn(II) competition results
in reduced Mn(II) accumulation and elicits a phenotype nearly
identical that of an isogenic DpsaA mutant. Reduced intracellular
Mn(II) perturbs bacterial growth as the capacity to manage
oxidative stress, which occurs during aerobic growth, is compro-
mised [23,28]. This is particularly noticeable during the outgrowth
of stationary phase cells, which showed impaired growth at
Zn(II):Mn(II) ratios of 100:1 and greater, while exponential phase
growing cells were inhibited at higher ratios, presumably as Mn(II)
was titred out by cell division. This may also indicate that Mn(II)
has distinct intracellular roles at different stages of S. pneumoniae
growth. Very high (.1 mM) concentrations of zinc completely
bacterial inhibited growth and it is likely that under these
conditions Zn(II) toxicity was mediated by mechanisms in addition
to competition for PsaA. Our findings also provide a physiological
rationale for the Zn(II)-dependent regulation of PsaR [37] as a
mechanism for regulating expression of the Mn(II) transporter
during exposure to high levels of the competing cation. Cluster A-
1 SBPs are present in a broad range of pathogenic bacteria, such
as S. pneumoniae, Yesinia pestis, Staphyloccocus aureus, and S. pyogenes
[19,31,32,41], and so the competitive mechanism of Zn(II) toxicity
proposed for S. pneumoniae could also extend to these bacteria.
This investigation also resolves an area of significant confusion
as to the presence of Zn(II) in the original crystal structure of PsaA
[18], which has remained contradictory to all of the physiological
Figure 3. In vitro effects on bacterial survival and in vivo metal
concentrations. (A) Paraquat killing of the S. pneumoniae wild-type
(D39) and DpsaA mutant grown in C+Y+1 mM Mn, and S. pneumoniae
grown in 100 mM Zn(II):1 mM Mn(II) (D39 100:1). Survival was calculated
as a percentage of colonies at 30 minutes compared to 0 minutes. The
experiment was performed with 3 independent biological samples
(n=3) and data are the means (6SEM). (B) PMN killing of S. pneumoniae
D39 and DpsaA mutant grown in C+Y+1 mM MnSO4, and S. pneumoniae
grown in 100 mM Zn(II):1 mM Mn(II) (D39 100:1). The experiment was
performed in triplicate (n=3) and shown data are means (6SEM). (C) In
vivo niche Zn(II) comparisons. Zn(II) accumulation determined by ICPMS
from mouse tissues of naı ¨ve (n=5) and S. pneumoniae-infected mice
(n=10). The statistical significance of the differences in the in vivo
mouse tissue Zn(II) concentrations was determined by a two-tailed
unpaired t-test. (D) In vivo niche Mn(II) comparisons. Mn(II) accumula-
tion determined by ICPMS from mouse tissues of naı ¨ve (n=5) and S.
pneumoniae-infected mice (n=10). The statistical significance of the
differences was determined by a two-tailed unpaired t-test. P-values of
,0.05, ,0.005 and ,0.0005 are denoted by *, ** or ***, respectively.
doi:10.1371/journal.ppat.1002357.g003
Table 1. Physiological ratios of tissue metal concentrations.
Zn(II)/Mn(II) Ratio
Sample Naı ¨ve (n=5) Infected (n=10) Fold Change*
Brain 33 93 2.8
Lung 39 96 2.4
Nasopharynx 63 336 5.3
Blood serum 37 905 24.4
*The statistical significance of the differences between the metal ion
concentrations before (naı ¨ve) and after (infected) infection for all samples were
analyzed using a two-tailed unpaired t-test. P-values for all analyses were at
least ,0.05.
doi:10.1371/journal.ppat.1002357.t001
Mechanism for Bacterial Susceptibility to Zinc
PLoS Pathogens | www.plospathogens.org 5 November 2011 | Volume 7 | Issue 11 | e1002357data for the role of the Psa permease in S. pneumoniae. Here we
show PsaA in complex with its physiological ligand and the
difference in the affinities for Mn(II) and Zn(II) confirm its
physiological role in Mn(II) acquisition. Our biophysical charac-
terization also provides an explanation for the presence of Zn(II) in
the original crystal structure. The thermal stabilization data show
that Zn(II) binding induces a highly stabilized from of PsaA and it
is highly likely that this would preferentially crystallize in
comparison to the less thermally stable apo- form of the protein.
This is also consistent with the behaviour of other Cluster A-1
Mn(II)-SBPs, all of which show a preference for Mn(II) but still
retain an interaction with Zn(II), albeit at a lower affinity.
Furthermore, consistent with the lack of solvent access to the
binding site in the metal loaded-PsaA structures, we observed that
Zn(II) could not be extracted from PsaA by chelating agents,
despite the protein’s lower affinity for the metal, or by competition
with Mn(II). This supports our observations that, at high ratios,
Zn(II) binding to PsaA could effectively inactivate the Psa
permease leading to impairment of Mn(II) uptake as shown in
our in vitro studies.
Our study also highlights the importance of Zn(II) during in vivo
infection and implicates a role for Zn(II) in the host immune
response. Dietary zinc deficiency is a global health issue that affects
2 billion people [42] and, in developing countries, zinc deficiency
is associated with a higher burden of respiratory disease [4,43]. In
recent years Zn(II) supplementation therapies have proven to be
efficacious in reducing the incidence of respiratory infections
[4,5,12,43]. These studies have also shown that inadequate dietary
Zn(II) can reduce mean blood serum Zn(II) concentrations by up
to 76%. Thus, dietary Zn(II)-deficiency can significantly reduce
the Zn(II):Mn(II) ratio in the blood and, presumably, other tissues
[4,5,43].
The association between Zn(II) and optimal immune function is
well known and our findings offer a plausible molecular
explanation for the protective role of zinc. We have shown that
Zn(II) concentrations were significantly elevated within 48 hours
of bacterial infection in all niches colonized by S. pneumoniae,
consistent with the importance of Zn(II) in the innate immune
response. Furthermore, a comparison between the naı ¨ve and
infected states clearly shows that the alterations in metal ion
concentrations in host niches were essentially Zn(II)-specific with
only isolated changes observed for other trace elements. We
propose that it is likely that the observed increase in Zn(II)
concentration in vivo is due to extracellular release of Zn(II) to
recruit immune effector cells [44,45] and to compete for Mn(II)
acquisition. This inference is consistent with the massive elevation
of the Zn(II):Mn(II) ratio in the nasopharynx and in blood serum,
two niches that were hyper-susceptible to S. pneumoniae colonization
in Zn(II)-deficient mice [38]. Furthermore, our observations are
also consistent with the recent findings of Corbin and co-workers
[13], who found that the Gram-positive pathogen Staphylococcus
aureus had a similar dependence on Mn(II) in abscess tissue, where
the host protein calprotectin was identified as mediating in vivo
Mn(II) restriction. Assessing in vivo metal ion bioavailability
remains a technical challenge, since even in blood serum, metal
ions may be sequestered in proteins and other carrier molecules.
Despite this caveat, which applies to this study and others such as
Corbin and co-workers [13], our data directly implicate the
specific elevation of Zn(II) as a major factor in host response to
infection.
Based on the available data we propose that, during in vivo
infection, Mn(II) bioavailability could be restricted due to
elevation of Zn(II):Mn(II) ratio by the release of Zn(II) from
damaged or apoptotic cells and from sequestering proteins such
as metallothionein. This would initially slow S. pneumoniae growth
while also increasing its susceptibility to oxidative killing, as it is
the ratio, not the absolute concentration of the two metal ions,
that is important. This would be consistent with the requirement
of Mn(II) uptake for S. pneumoniae infection in vivo, as the DpsaA
mutant is totally avirulent [27,28,29]. Zn(II) was released during
infection at high ratios relative to Mn(II) in the nasopharynx and
in blood serum. In our in vitro studies, these ratios were inhibitory
and it is not unreasonable to speculate that these ratios in vivo
could obfuscate Mn(II)-PsaA interactions and thereby induce a
Mn(II)-starvation phenotype in the invading pathogen. The
host release of Zn(II) would have the additional benefit of also
driving recruitment of leukocytes and other components of the
innate immune response [44,45]. The cumulative effect of this
would be that elevation of the Zn(II):Mn(II) ratio in vivo would
also increase the susceptibility of S. pneumoniae to oxidative killing
by immune effector cells, such as PMNs, as we have shown in
vitro, thereby facilitating more efficient defence against the
invading pathogen.
PMNs are a major component of the innate response and in
addition to their oxidative killing mechanisms they contain large
stores, up to 50% of their total protein, of the metal binding
protein calprotectin [46]. Corbin and co-workers [13] first
postulated that calprotectin could be released and directed at
bacterial pathogens as a mechanism for restricting metal ion
availability in vivo. Supporting this inference, they observed that
calprotectin-deficient mice had increased abscess formations and
bacterial burdens relative to infected wild-type animals. Release of
calprotectin by PMNs during the immune response could also
have a significant effect on the Zn(II):Mn(II) ratio, by sequestering
Mn(II). This would increase the susceptibility of invading bacteria
to oxidative killing mechanisms, consistent with both the earlier
suggestions of Corbin and co-workers [13] and in our model for in
vivo Mn(II) starvation of the invading bacterium.
Collectively, this study demonstrates the biophysical basis of
metal specificity for an essential bacterial cell-surface protein and
its importance for bacterial propagation. We have provided direct
evidence of how the usually non-toxic metal ion Zn(II) mediates
toxicity to S. pneumoniae, namely by competition for Mn(II)
acquisition leading to intracellular Mn(II) starvation. Furthermore,
we have provided a molecular explanation for how this could be
harnessed and exploited by the innate immune system to heighten
the bacterium’s sensitivity to immune effector cells. This has great
significance in the context of the nutritional importance of Zn(II)
and its association with optimal immune function.
Materials and Methods
Ethics statement
All procedures performed in this study were conducted with a
view to minimising the discomfort of the animals, and used the
minimum numbers to generate reproducible and statistically
significant data. All experiments were approved by the University
of Adelaide Animal Ethics Committee (Animal Welfare Assurance
number A5491–01; project approval number S-2010–001) and
were performed in strict adherence to guidelines dictated by the
Australian Code of Practice for the Care and Use of Animals for
Scientific Purposes.
Expression and purification of wild-type and mutant
derivatives of PsaA
High-level expression and purification was conducted as
described previously [47]. PsaA was enriched for Mn(II) by
harvesting cells and purification in the presence of 5 mM MnSO4.
Mechanism for Bacterial Susceptibility to Zinc
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previously [28].
Apo-PsaA generation and ICPMS
Demetallated (apo) PsaA was prepared from Mn(II)-enriched
PsaA (50 mM) that was heated to 62.5uC in the presence of
0.5 mM EDTA for 5 minutes. The sample was then cooled for
10 min, centrifuged and 18,000 6 g for 10 min and the
supernatant desalted on a PD10 column (GE Healthcare). The
sample was analyzed for Zn(II) and Mn(II) content by boiling
10 mM protein at 95uC for 20 min in 3.5%, 7% or 14% HNO3.
Samples were analyzed on an Agilent 7500cx ICP-MS (Adelaide
Microscopy, University of Adelaide). Routine treatment used 3.5%
HNO3 as no differences were found in the quantity of metal
released. Apo-PsaA was defined as having less than 10% total metal
content on a mol metal/mol PsaA basis.
Construction and cloning of Glu205RGln and
Asp280RAsn mutants of PsaA
Point mutants were constructed by overlap extension PCR,
essentially as described previously [48]. The mutants were
confirmed to be in-frame by PCR and sequence analysis using
primers flanking each gene in question. The primers used for
construction and validation of the mutants are listed in Table S5.
Overlap extension products were then cloned, in frame, into the
respective restriction sites in pQE30 (Qiagen, Germany).
Biophysical analyses
ITC was performed using a VP-ITC unit (Microcal, USA) with
apo-PsaA, 4.5, 10, 15 or 20 mM, in 20 mM sodium phosphate
buffer, pH 6.5 at 25uC. Samples were centrifuged and degassed
prior to analysis. MnSO4 was injected at 3 min intervals with 56
injections of 4 ml with a 10 second injection time. ZnSO4 was
injected at 3 min intervals with 28 injections of 10 ml with a 20
second injection time. A stir rate of 307 per min was used in both
experiments. Data were analyzed using the Origin 7.0 software
(Microcal) and the parameters (6 SEM) determined. The thermal
shift assay was based on the Thermfluor assay [49] conducted
using 10 mM PsaA in 100 mM MOPS, pH 7.2, 150 mM NaCl,
56 SYPRO Orange (Invitrogen) in the presence of 10 mMt o
1000 mM metal, using a Roche LC480 Real-Time Cycler. For
further details see Text S3.
In vitro growth measurements
Frozen stock S. pneumoniae D39 were prepared as described
previously [28]. For in vitro growth measurements, frozen stock
culture was added to C+Y with 1 mM MnSO4 and supplemented
with ratios of metal ions as specified. The starting A600 was 0.05 for
all cultures. For the Zn(II) challenge experiment a frozen stock
culture was added to C+Y with 1 mM MnSO4 to a starting A600 of
0.05 and grown to an A600 of 0.3. Cells were washed with C+Y, pre-
warmed to 37uC, and then reinoculated into C+Y with 1 mMM n
SO4 and supplemented with 100 mM, 300 mM or 1 mM ZnSO4,t o
an A600 of 0.2. Cell growth was then monitored at A600. All analyses
were carried out in at least biological triplicate. Bacteria prepared in
this manner were washed twice, each in 10 volumes of PBS, before
western blotting. For ICPMS analyses cells were washed 3 times,
14,000 xgfor 10 min, in PBS +5 mM EDTA and then washed 3
times with PBS. The dry cell mass was determined and the material
boiled at 95uC for 20 min in 3.5%, 7% or 14% HNO3. The metal-
ion containing supernatant was collected by centrifugation at
14,000 xgfor 30 min and metal content determined on an Agilent
7500cx ICPMS (Adelaide Microscopy, University of Adelaide).
Routine treatment used 3.5% HNO3 as no differences were found
in the quantity of metal released.
In vivo metal content determination
Outbred 5–6 week old female CD1 (Swiss) mice were used in
these experiments, under the approval of the Animal Ethics
Committee of The University of Adelaide. For metal content
determination in naı ¨ve mice (n=5), samples of nasopharynx,
lungs, blood and brain were harvested as described previously
[50], using PBS only (without trypsin or EDTA). For metal content
determination in mice challenged with pneumococci (n=10) were
infected intranasally with approx. 10
7 c.f.u. of S. pneumoniae D39,
following the procedures described previously [50]. Mice were
sacrificed at 48 hr-post-infection and samples of nasopharynx,
lungs, blood and brain of each mouse were harvested and
processed as described previously [50], again using PBS only.
Tissue samples were analyzed for mass, except blood serum, and
boiled in 3.5% HNO3 for 20 min at 95uC. Blood serum was
diluted in 7% HNO3 and boiled for 20 min at 95uC. The metal-
ion containing supernatant was collected by centrifugation at
14,000 xgfor 30 min and metal content determined on an Agilent
7500cx ICPMS (Adelaide Microscopy, University of Adelaide).
The tissue concentrations of metal ions were calculated using the
mass or volume of tissue dissolved in HNO3.
Real-time RT-PCR
One-step relative quantitative real time RT-PCR using a Roche
LC480 Real-Time Cycler, was performed as described previously
[48]. The psaA primers are listed in Table S4 and were used at a
final concentration of 200 nM per reaction. 16S rRNA was
employed as a control. Amplification data were analyzed using the
comparative critical threshold (2
2DDCT) method [48].
Crystallization, data collection and structure
determination
Manganese-enriched IMAC-purified protein was further puri-
fied on a HiLoad 26/60 column. The protein was eluted in 0.2 M
MnSO4, 0.2 M NaCl and 20 mM HEPES/NaOH, pH 7.5 at
20uC. The peak-containing fractions were analyzed for purity
by SDS-PAGE and selected fractions were concentrated to
18 mg.ml
21 using Amicon Ultra-4 centrifugal devices (Millipore).
The crystals of the Mn(II)-bound form were optimized by several
rounds of microseeding utilizing the nuclei of Mn(II)-bound PsaA
crystals obtained by vapour diffusion in hanging drops at 18uC
essentially as conducted previously [18]. The seed was introduced
into a drop equilibrated overnight and containing 1 ml of protein
and 1 ml of reservoir solution containing 33% PEG 1500, 0.15 M
SPG buffer pH 4.0, 0.2 M MnSO4 suspended over 0.5 ml of
reservoir solution. SPG buffer was produced by mixing succinic
acid, sodium dihydrogen phosphate, and glycine in the molar
ratios 2:7:7 and pH adjusted by adding 10 N NaOH. Crystals
grew to the maximum size of 200 mm x 200 mm x 100 mm within
7–10 days. For data collection, the crystals were cryoprotected
with 20% glycerol before being flash-cooled by rapid immersion in
liquid nitrogen. The diffraction data were collected on a single
crystal on the MX2 microfocus beamline of the Australian
Synchrotron [51] (Melbourne, Australia) operating at 6545 eV
(for details and refinement statistics see Table S6). For further
details of the data collection and analysis see Text S3.
Bacterial killing assays
Bacteria were grown to an A600=0.3 in minimal media with or
without Zn(II) supplementation, washed 3 times with PBS
Mechanism for Bacterial Susceptibility to Zinc
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PBS. Cells were incubated for 30 minutes with 60 mM paraquat
(Sigma-Aldrich) and then serially diluted and plated on blood-
agar. Plates were incubated overnight at 37uC +5% CO2. Survival
was calculated as a percentage of colonies at 30 minutes compared
to 0 minutes. The PMN killing assay was adapted from [52], and
further details are provided in Text S3.
Supporting Information
Figure S1 PsaA-Mn(II) structural comparisons. (A) PsaA-
Mn(II) (PDB ID: 3ZTT) overlayed with MntC-Mn(II) (PDB ID:
1XVL). Superposition was performed using COOT (see Text S2
for further details) using the SSM structural alignment function
(34.2% sequence identity; RMSD=1.31 A ˚ for 266 Ca atoms).
PsaA shown in green and MntC is in blue. The metal binding site
residues are also shown and the Mn(II) ions are shown as purple
spheres. (B) The metal binding site from S1A is shown in more
detail, with the MntC residues and Mn(II) labels italicised.
(C) PsaA-Mn(II) (green) overlayed with PsaA-Zn(II) (blue) using
COOT (RMSD=0.496 A ˚ for Ca atoms). (D) The metal binding
site from S1C is shown in more detail. The manganese ion is
shown as a purple sphere and zinc ion is shown as an orange
sphere. The imidazole ring of His-139 is rotated 31 degrees to
accommodate the larger atomic volume of the Mn(II) atom in the
PsaA-Mn(II) structure but this has no effect on the metal ion
distance to the N
e2 ligand.
(TIF)
Figure S2 Thermal stability of PsaA mutants. The
thermal unfolding of the protein was followed by the presence of
the SYPRO Orange fluorescent probe. The samples were pre-
incubated for 10 minutes with the indicated metal ion concentra-
tion and then subjected to thermal unfolding from 25uCt o9 7 uCa t
a heating rate of 1uC per minute. The normalized inverse plot of
the first derivative of the fluorescence over temperature allows for
accurate determination of the Tm after background subtraction.
The sets of curves are representative of three independent
experiments. (A) PsaA Gln205 with saturating concentrations of
Mn(II) or Zn(II) (100-fold excess). (B) PsaA Asn280 with saturating
concentrations of Mn(II) or Zn(II) (100-fold excess).
(TIF)
Figure S3 In vitro metal competition effect on psaA
expression. (A) Western blot analysis of lysates of S. pneumoniae
D39 grown in C+Y medium consisting of the following
Zn(II):Mn(II) ratios: 100:1, 10:1, 1:1, respectively. Blots are from
two biological replicates for each growth condition. (B) psaA gene
mRNA concentrations from S. pneumoniae D39 grown in C+Y
medium consisting of different Zn(II):Mn(II) ratios, relative to
concentrations obtained from Zn(II):Mn(II) (1:1) ratio. Real-time
RT-PCR data for the indicated conditions were normalized
against those obtained for the 16S rRNA control. Quantitative
fold differences for the psaA transcript were determined using the
2
-DDC
T method
30. Data are means (6 SEM) of duplicate reactions
from two biological replicates.
(TIF)
Table S1 Purified PsaA Metal Content (mol metal/mol
protein).
(DOC)
Table S2 Thermal stability of 10 mM PsaA at different
metal ion concentrations.
(DOC)
Table S3 S. pneumoniae metal ion competition.
(DOC)
Table S4 In vivo niche metal concentrations.
(DOC)
Table S5 Oligonucleotide primers used in this study.
(DOC)
Table S6 PsaA-Mn(II) structure data collection and
refinement statistics.
(DOC)
Text S1 Isothermal calorimetric analysis of PsaA.
Interpretation of the ITC analysis of PsaA presented in Fig. 1A
and B.
(DOC)
Text S2 Crystallographic analysis of PsaA-Mn(II). Inter-
pretation of the PsaA-Mn(II) crystal structure presented in Figs. 1C,
D, and S1.
(DOC)
Text S3 Supporting Methods and References.
(DOC)
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